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Riboswitches are genetic control elements present mainly in the 50 untranslated regions of messen-
ger RNAs that, upon binding of a small metabolite (like some vitamins, amino acids, and nucleo-
bases), undergo conformational changes, affecting the expression of downstream genes. Structural
studies of riboswitches are important for understanding how they recognize their ligands with high
specificity and affinity. The thiamin pyrophosphate binding riboswitch (THI- box) is widely distributed
in the three kingdoms of life and is involved in very distinct modes of gene regulation. Three recent
THI-box structural analyses revealed howpolyanionicRNA is able to bind amoleculewith a negatively
charged pyrophosphate group like thiamin pyrophosphate (TPP) and how it can discriminate be-
tween TPP and monophosphorylated analog molecules. These studies give insight into the genetic
regulatory mechanisms in which the THI-box is involved.Introduction
Our view of the functions that RNA can perform in the cell
has dramatically changed. First recognized as a transmit-
ter of genetic information (mRNA) and as an adaptor mol-
ecule in protein synthesis (tRNA), now RNA is known to
work as a carrier of genetic information (in viruses and ret-
roviruses), as a catalyst (ribozymes), as a catalytic subunit
in a supramolecular complex (the ribosome is a ribozyme),
and as a substrate for modification by epigenetic control
(RNA editing, alternative splicing) (Joyce, 2002). In addi-
tion, some RNAs have an important and decisive role as
regulators of gene expression (small RNAs in bacteria
and microRNAs in eukaryotes), a role that was thought
to be exclusive to proteins (Storz et al., 2005).
The ability of mRNA molecules to undergo localized
conformational changes that alter their expression upon
the specific recognition of a small molecule (like tRNA or
small metabolites) is the basis of some mechanisms of
gene regulation (Grundy and Henkin, 2006). In 1993, it
was shown that the binding of uncharged tRNA to the
leader mRNA of aminoacyl tRNA syntethase genes of Ba-
cillus subtilis leads to the formation of an anti-terminator,
allowing the expression of the synthetase gene. When
the cellular concentration of charged tRNA is sufficient,
the mRNA adopts an alternative conformation that results
in transcription termination and, hence, repression
(Grundy and Henkin, 1993). This regulatory element was
named the T box and is present in Gram-positive bacteria.
In other cases, the leader mRNA interacts with metabo-
lites like vitamins, amino acids, or nucleobases as part of
a feedback regulatory loop (Winkler and Breaker, 2003).
The first examples of this new regulatory mechanism
were found studying the regulation of the biosynthetic en-
zymes producing vitamins B2, B12, and B1 (riboflavin, cya-
nocobalamin, and thiamin, respectively). Genes regulatedStructuby these vitamins have 50 untranslated regions (UTRs) that
contain highly conserved sequences shown to be impor-
tant for regulation (Gelfand et al., 1999; Nou and Kadner,
2000; Miranda-Rı´os et al., 2001; Stormo and Ji, 2001).
As no regulatory protein that interacted with the UTR
was identified for any of these systems despite consider-
able searching, it was proposed that the 50UTRs were ex-
amples of natural aptamers that would be able to bind the
vitamins and repress the expression of biosynthetic and
transport genes themselves (Gelfand et al., 1999; Mi-
randa-Rı´os et al., 2001; Stormo and Ji, 2001). Binding of
the vitamins to in vitro transcribed RNAs containing the
conserved ‘‘aptameric’’ sequences confirmed this pro-
posal and gave insight into the regulatory mechanisms
involved (Winkler and Breaker, 2005).
In general, the binding of the effector molecule induces
a conformational change in the mRNA that either causes
the premature termination of transcription in Gram-posi-
tive bacteria via formation of a Rho-independent tran-
scriptional terminator or causes the inhibition of transla-
tion initiation in Gram-negative bacteria by masking of
the Shine-Dalgarno (SD) sequence (off state). In the latter,
when the level of the effector drops below its affinity for the
riboswitch, the mRNA adopts an alternative conformation
allowing expression of the gene by formation of an anti-
terminator or anti-SD stem loop (on state) (Figure 1). These
new genetic control elements containing a binding site for
the metabolite and the RNA elements (transcription termi-
nator stems or sequesters of the SD) that affect gene ex-
pression were given the name riboswitches, a name that,
in the opinion of the author, should also include the
mRNAs that interact with uncharged tRNA molecules.
Modulation of gene expression by ligand-induced alloste-
ric changes in the riboswitches is reminiscent of gene reg-
ulation mediated by protein transcription factors like there 15, March 2007 ª2007 Elsevier Ltd All rights reserved 259
Structure
MinireviewFigure 1. Mechanisms of Genetic
Regulation Mediated by Riboswitches
When the concentration of the small metabolite
drops below its affinity for the riboswitch, gene
expression is allowed (on state). Binding of the
metabolite to the riboswitch leads to gene re-
pression (off state) by means of premature
transcription termination (top) or inhibition of
translation initiation (middle) in prokaryotic or-
ganisms. Binding of TPP to the THI-box ribos-
witch is also known to exert regulation at the
level of splicing in eukaryotic organisms (bot-
tom). Small metabolites in general and TPP
in particular are shown as a brown or orange
ellipse, respectively. SD represents the Shine-
Dalgarno sequence. Divalent cations that co-
ordinate the pyrophosphate group of TPP are
depicted as asterisks.trp repressor of Escherichia coli that changes its confor-
mation and is able to bind to DNA only if it is bound to
the amino acid tryptophan (Shimizu et al., 1973).
In addition to the riboflavin-, cyanocobalamin-, and
thiamine-binding riboswitches (FMN-box, B12-box, and
THI-box, respectively), there are other riboswitches that
are involved in the regulation of biosynthesis and/or trans-
port of guanine (G box [Johansen et al., 2003; Mandal
et al., 2003]), lysine (L box [Kochhar and Paulus, 1996;
Grundy et al., 2003]), magnesium (Cromie et al., 2006),
and three completely different sequences that are in-
volved in sulfur and methionine metabolism (S box, SMK
box, and SAM-II box [Grundy and Henkin, 1998; Fuchs
et al., 2006; Corbino et al., 2005]). Four riboswitches stand
out as they act by distinct regulatorymechanisms. The ad-
enine and glycine riboswitches activate gene expression
upon ligand binding (Mandal and Breaker, 2004; Mandal
et al., 2004). The glmS riboswitch uses binding of glucos-
amine-6-phosphate to stimulate self-cleavage of the
mRNA repressing its expression (Winkler et al., 2004). Fi-
nally, the THI-box regulates intron splicing inAspergillus in
addition to regulating premature transcription termination
and translational inhibition in prokaryotes (Kubodera et al.,
2003).
Three characteristics determine the function of any RNA
molecule: its sequence, its secondary structure, and its
folding into complex 3D structures. This review focuses
on what is known about these three characteristics of
the THI-box riboswitch.
The THI-Box Sequence Is Evolutionarily
Widespread and Functionally Diverse
Thiamin, or vitamin B1, is a water-soluble vitamin. Struc-
turally, it consists of a substituted pyrimidine ring joined
by a methylene bridge to a substituted thiazole. Thiamin
pyrophosphate (TPP), also named thiamin diphosphate
or cocarboxylase, is the biologically active form of260 Structure 15, March 2007 ª2007 Elsevier Ltd All rights resethiamine (Figure 2A). TPP functions as cofactor of impor-
tant enzymes that are involved in carbohydrate metabo-
lism. Some thiamin biosynthetic and transport genes con-
tain a conserved sequence named THI-box for thiamin
regulatory box in their 50UTRs (Miranda-Rı´os et al., 1997;
Rodionov et al., 2002). The THI-box was shown to be re-
sponsible for the repression by thiamin of thiamin biosyn-
thetic genes (Miranda-Rı´os et al., 2001).
The THI-box has been found in the a-, b-, g-, and 3-pro-
teobacteria, in cyanobacteria, the CFB group, the Ther-
mus/Deinococcus group, the Bacillus/Clostridium group,
and in actinomycetes and thermotogales (Rodionov
et al., 2002). It is also present in archaebacteria, in the or-
der Thermoplasmatales of the phylum Euryarchaeota, but
it seems that it has been acquired by an event of horizontal
transfer (Miranda-Rı´os et al., 2001). The THI-box is the
only riboswitch that has been found in eukaryotes: it is
found as part of an intron in fungi and within the 30UTR
of plants (Kubodera et al., 2003; Sudarsan et al., 2003).
The THI-box is remarkable for how it is used in different
regulatory contexts: inhibition of translation and prema-
ture transcription termination in Gram-negative and
Gram-positive bacteria, splicing control in fungi (Kubo-
dera et al., 2003), and the postulated control of processing
or stability of plant mRNAs (Sudarsan et al., 2003).
One important characteristic of the THI-box is its ca-
pacity to bind TPP without the intervention of any protein.
Solution experiments to look at THI-box secondary and
tertiary structure by spontaneous backbone hydrolysis
on two in vitro transcribed THI-boxes from E. coli showed
that in the presence of TPP, different areas of the ribos-
witch became cleavage resistant, indicating a conforma-
tional change upon binding of the ligand (Winkler et al.,
2002). Apparent dissociation constants of 0.1 mM and
100 mM for TPP and thiamin monophosphate (TMP), re-
spectively, were derived from those experiments, thus
showing a discrimination of 1,000-fold between therved
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et al., 2002). The intracellular thiamin concentration has
been experimentally obtained and found to be in the range
between 0.25 mM and 4.5 mM. The apparent dissociation
constant values found for the different THI-boxes are
thus well-suited to work in this range (Schyns et al., 2005).
Structure of the THI-Box
Phylogenetic and biochemical analyses provided a sec-
ondary structure model of the THI-box, consisting of five
Figure 2. Chemical Structure of TPP and Sequence,
Secondary Structure, Tertiary Interactions, and Conserved
Residues of the THI-Box Riboswitch
A) Chemical structure of thiamine pyrophosphate. The pyrimidine
group of TPP is on the left, the thiazole ring is in the center, and the
pyrophosphate group is on the right.
B) Secondary structure and tertiary interactions in TPP-bound THI-box
located upstream of the E. coli thiM gene. Nucleotides conserved in at
least 97% of all known THI-box riboswitches are shown in uppercase
letters. Residues that bind the pyrimidine and pyrophosphate moieties
of TPP are shown in yellow and orange shading, respectively. Resi-
dues that contact Mg+2 ions MA, MB, MC, and MD are shown in cyan,
pink, red, and blue shading, respectively. Residues involved in tertiary
interactions are depicted in green shading. Noncanonical base pairs
are shown by + symbols. TPP is schematized by thick red lines ending
with P-P.Struchelices (P1–P5) arranged in two parallel helical domains
connected to helix P1 (Rodionov et al., 2002; Winkler
et al., 2002) (see Figure 2B). But the answers to questions
such as what is the tertiary structure of the THI-box, what
residues are involved in the binding of TPP, how can it dis-
criminate 1000-fold between TPP and TMP, and the more
general question of how can a polyanionic molecule like
RNA recognize a negatively charged pyrophosphate
group had to wait until high-resolution crystal structures
were available.
The structures of the Arabidopsis thaliana thiC and
E. coli thiM riboswitches that have been recently reported
shed light on these questions (Thore et al., 2006; Serganov
et al., 2006; Edwards and Ferre´-D’Amare´, 2006). The
structures of the THI-boxes from bacterial and plant origin
are highly similar, representing an exciting example of
conservation in evolutionarily distant organisms, and are
in complete agreement with the secondary structure
model predicted by phylogenetic and biochemical analy-
ses. The overall structure of the THI-box resembles a tun-
ing fork in which the prongs are formed by two parallel
stacking helices (P2, bulge J3-2, P3, and loop L3) and
(P4, bulge J4-5, P5, and loop L5) arranged via a central
three-way junction with helix P1 (Figures 2B and 3A).
The purine- and SAM-binding riboswitches show a similar
architecture consisting of 3 and 4 helical junctions, re-
spectively (Figures 3B and 3C) (Batey et al., 2004; Serga-
nov et al., 2004; Montange and Batey, 2006).
Each of the parallel helices has a function in binding one
part of TPP. Helix P2/J3-2/P3/L3 is involved in binding the
pyrimidine moiety, and helix P4/J4-5/P5/L5 binds the
pyrophosphate group. The binding sites are found in
deep pockets where TPP is situated perpendicular to
the two parallel helices, with the pyrimidine group com-
pletely buried in the RNA (Figure 4A). The TPP bound to
the THI-box is present in an extended conformation, sim-
ilar to the conformation seen in free TPP and in contrast to
the V-conformation that is found when TPP is bound to
TPP-dependent enzymes (Muller et al., 1993).
The pyrimidine part of TPP is bound by bulge J3-2
located in the pyrimidine-sensor helix P2-P3 that contains
the conserved sequence UGAGA. Residues U39 and A43
form a trans-Watson-Crick/Hoogsteen base pair that
causes the extrusion of residuesG40, A41, andG42, form-
ing a type I T-loop motif (Nagaswamy and Fox, 2002). The
pyrimidine ring is held between residues G42 and A43
(present in a C20 endo conformation) bymeans of stacking
forces and the formation of two hydrogen bonds with res-
idueG40 and one hydrogen bond between the N1 position
of the pyrimidine ring of TPP and the 20 oxygen of residue
G19 (Figure 4A). Further stabilization is attained by the
formation of a pair of triples: (G19$A47)$G42 and (G18-
C48)$A41 (Serganov et al., 2006).
The pyrophosphate group of TPP is recognized by the
J4-5 internal loop present in the pyrophosphate-sensor
helix P4/P5 through an interaction with divalent cations
and their corresponding coordinated water molecules
(Figure 4A). In the structure published by Thore et al.
(2006), only one discernible Mg2+ ion is found in theture 15, March 2007 ª2007 Elsevier Ltd All rights reserved 261
Structure
MinireviewFigure 3. Three-Dimensional Structures of the THI-Box, Guanine, and SAM Riboswitches
The THI-box (A), guanine (B), and SAM riboswitches (C) are depicted in ribbon representations. TPP, guanine and SAM ligands are depicted as
spheres and colored by element. Data was obtained from pdb files 2HOJ, 1Y27 and 2GIS for the THI-box, guanine and SAM riboswitches, respec-
tively. Molecular modeling was done with the program UCSF Chimera (http://www.cgl.ucsf.edu/chimera; Pettersen et al., 2004).neighborhood of the pyrophosphate group, while Serga-
nov et al. (2006) found two Mg2+ ions. These results lead
to some uncertainty about the actual number of Mg2+
ions that bridge the pyrophosphate group of TPP and
the RNA. In the paper by Edwards and Ferre´-D’Amare´
(2006), an anomalous difference Fourier analysis of crys-
tals grown in the presence of Mn2+ was performed that
showed the pyrophosphate coordinated by two Mn2+
ions. The presence of two divalent cations (MA and MB)
was also corroborated by the analysis of crystals grown
in a mixture of Mg2+ and Ca2+ and from crystals soaked
in the presence of Ba2+ ions (Edwards and Ferre´-D’Amare´,
2006).
The only residue found tomake a direct contact with the
pyrophosphate group is the highly conserved G78. It
forms a hydrogen bond between its N1 proton and a non-
bridging oxygen of the b-phosphate of TPP in a commonly
used bindingmode for phosphate and carboxylate groups262 Structure 15, March 2007 ª2007 Elsevier Ltd All rights reseby RNAs (Auffinger et al., 2004). This residue as well as
residue G60 interacts directly with MA. Residues U59,
A61 and C77 also interact with MA through a water mole-
cule each. Residues A75, G76 and C77 interact with MB
through water molecules (Figure 4A). It seems that TPP
and the two divalent cations bind concomitantly to the
RNA, since in THI-box crystals grown in the presence of
pyrithiamine, a pyridine analog of thiamin that lacks the
pyrophosphate group, no metal ions are associated to
the RNA (Edwards and Ferre´-D’Amare´, 2006).
The involvement of divalent cations in the interaction
between the THI-box RNA and the pyrophosphate group
of TPP was documented in a previous report where by
means of circular dichroism spectra, it was shown that
the affinity of the THI-box for TPP increased 50-fold in
the presence of physiological concentrations of Mg2+
(1 mM) (Yamauchi et al., 2005). The interaction between
the pyrophosphate and the RNA is also supported byFigure 4. Mode of Binding of TPP and Tertiary Interactions Present in the THI-Box Riboswitch
A) Two regions of the THI-box RNA interact with TPP. Nucleotides involved in binding the pyrimidine and the pyrophosphate moieties of TPP are
shown in green and red, respectively. Divalent cationsMA andMB, used to bind the pyrophosphate group to the RNA, are shown asmagenta spheres.
B) Tertiary interactions formed by nucleotides G21, C38, and U39 at the base of P3 helix of the pyrimidine-sensor helix and nucleotides A69, A70, and
U71 of the L5 hairpin loop bring the two prongs of the tuning fork shape into proximity.
C) A84 anchors formation of a kink at residue A53 that allows the proper alignment of the pyrimidine- and pyrophosphate-sensor helices and the
formation of the switch P1 helix. The ribose ring of residue G51 is shown in red. Data for preparation of the figures was taken from the PDB file
2HOJ. Molecular modeling was done with the UCSF Chimera program.rved
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copy to study the THI-box-TPP-Mg2+ interaction (Noeske
et al., 2006). This RNA-TPP-Mg2+ interaction was identi-
fied on the basis of pyrophosphate chemical shift changes
observed only in the presence of both RNA and Mg2+ and
further supported by paramagnetic relaxation of the pyro-
phosphate peaks in the presence of Mn2+ (Noeske et al.,
2006). Like the THI-box riboswitch, the glmS riboswitch,
whose ribozyme activity is enhanced by binding of an
effector molecule, glucosamine-6-phosphate, binds the
phosphate group of the competitive inhibitor glucose-6-
phosphate through coordination with a Mg2+ ion (Klein
and Ferre´-D’Amare´, 2006).
In addition to the Mg2+ ions involved in pyrophosphate
binding, two other divalent cations are known to partici-
pate in folding of the RNA. One (MC) seems to help in
the formation of the pyrimidine binding pocket by bending
the J3-2 bulge through interactions with residues U39 and
G40. The other ion (MD) connects the P3 and P5 helices
when they are brought close together apparently by the
binding of TPP. By comparison with structures of crystals
grown in the presence of Mn2+ or soaked in Ba2+, it was
shown that MD is exclusively occupied by Mg
2+, while
MC can be replaced by Mn
2+ or Ba2+ (Edwards and
Ferre´-D’Amare´, 2006).
Finally, two tertiary interactions bring together the py-
rimidine and pyrophosphate sensor helices. One involves
residues A69, A70, and U71 located in hairpin loop L5 and
residues G21, C38, and U39 present at the base of helix
P3 (Figure 4B). In the structure reported by Serganov
et al. (2006), three K+ ions stabilize the interaction between
L5 and P3, while Edwards and Ferre´-D’Amare´ (2006)
found that a divalent cation is used for stabilization. With
the exception of U39, nucleotides of interface L5/P3 are
poorly conserved, so alternative tertiary contacts should
be used in other THI-box riboswitches.
The other interaction results in the formation of a kink at
residue A53 situated at the J2-4 bulge that allows the py-
rimidine and pyrophosphate helices to be aligned in paral-
lel. This orientation is accomplished through the formation
of a pair of stacked tetrads between the noncanonical
base pairs A56$G83 and A53$A84 and the minor groove
of the G-C pairs present in helix P2. Formation of the
three-way junction is favored by hydrogen-bonding inter-
actions between residue A84 and residues G16 and C50,
in addition to stacking interactions between residues A84
and A56 and between A84 and the ribose ring of G51
(Figure 4C). This arrangement of the J2-4 domain helps
to stabilize the kink at residue A53 and aids in the forma-
tion of the P1 helix upon TPP binding. The importance of
residues A84 and C50 in the proper alignment of the two
parallel helices for binding of TPP is supported by the
fact that cells that are resistant to the thiamin antimetabo-
lite pyrithiamine are mutated in these residues (Kubodera
et al., 2000; Sudarsan et al., 2005). Tertiary interactions
have been found to be important for the proper folding
of other riboswitches. In the purine-binding riboswitch,
the interaction between the terminal loops, although not
directly involved in ligand binding, was found to be essen-Structtial for ligand recognition (Figure 3B) (Batey et al., 2004). In
the SAM-binding riboswitch, a kink-turn motif bends one
of the helices toward the other, allowing the formation of
a pseudoknot (Figure 3C) (Montange and Batey, 2006).
The structure of the THI-box RNA allows modelling of
the TPP-induced conformational changes between the
ligand-free on state and the ligand-bound off state. It is en-
visaged that binding of TPP forces the parallel disposition
of the pyrimidine and pyrophosphate sensor helices and
that this will lead to the formation of a kink at the J2-4 junc-
tion. This alignment will allow the formation of the P1 helix
and the formation of a terminator stem or a sequester of
the SD (off state).When the concentration of the TPPdrops
below its affinity for the THI-box, the P1 helix will not form
and the RNA will adopt an alternative conformation, since
the free 30 strand of the helix P1 will be able to participate
in the formation of either an anti-terminator hairpin or in
opening the SD sequence for ribosome binding (on state),
as depicted in Figure 1. Stabilization of the P1 helix in the
presence of TPP is supported by in-line probing experi-
ments that showed reduced cleavage of residues of helix
P1 upon binding of TPP (Winkler et al., 2002). Stabilization
of P1 helices in the purine- and SAM-binding riboswitches
has also been shown to be important for explaining the
ability of these RNAs to adopt alternative conformations
for the on and off states (Batey et al., 2004; Serganov
et al., 2004; Montange and Batey, 2006). As all of the
riboswitches known, with the exception of the glmS ribos-
witch, have a helix P1 in their secondary structure, it is rea-
sonable to think that they will work in a similar fashion.
In the paper by Serganov et al. (2006), it was proposed
that the difference of the affinities shown in vitro by the
THI-box for TPP and TMP could be explained if the THI-
box binding pocket for TPP is like a molecular ruler that
discriminates against TMP for being shorter by one phos-
phate group. As crystallization of the THI-box in the
presence of TMP and other monophosphorylated thiamin
analogs showed that the THI-box recognizes them in
a structurally similar way by adopting a more compact
conformation, the observeddifferences in affinity can be ex-
plainedby less-than optimal contacts between theRNAand
the smaller ligands (Edwards and Ferre´-D’Amare´, 2006).
The way in which the THI-box changes its conformation
to accommodate the ligands of different lengths is remi-
niscent of the induced fit that in vitro selected aptamers
use to interact with small molecules (Hermann and Patel,
2000).
Further Questions about the THI-Box
and Other Riboswitches
Several questions still remain about the riboswitches and
their function. There are 12 riboswitches with assigned
function. There are six orphan riboswitches present up-
stream of B. subtilis genes of unknown function, so the
identity of the ligands that they bind has not been deter-
mined (Barrick et al., 2004). With the avalanche of ge-
nomes that are being sequenced, how many more ribos-
witches are waiting for discovery? Is the THI-box the
only riboswitch present in eukaryotes and archaea?ure 15, March 2007 ª2007 Elsevier Ltd All rights reserved 263
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THI-box, adenine, guanine, SAM, and glmS riboswitches
have been published. Work on the three-dimensional
structures of the other eight riboswitches is needed to
know how they bind their ligands and the details of their
three-dimensional architectures. In particular, it will be in-
teresting to know if the riboswitches that bind other phos-
phorylated metabolites like cyanocobalamin and flavin
mononucleotide use positively charged metal ions for
binding the negatively charged phosphate group, as do
the THI-box and the glmS riboswitches. A deeper under-
standing of how the predominantly bacterial riboswitches
bind their ligands will also be useful in the design of new
specific antimicrobial drugs. As riboswitches must fold
rapidly while the transcript is being synthesized in order
to accomplish their regulatory role, other important as-
pects of riboswitch function that deserve attention are
the study of RNA folding, the kinetics of ligand binding,
and the speed of transcription (Wickiser et al., 2005; Le-
may et al., 2006). As RNA pausing helps in the synchroni-
zation of these processes, the study of the sequence de-
terminants of pausing and the functional characterization
of the proteins involved is also needed. Finally, another as-
pect worth studying is the comparison of the ligand affin-
ities shown by the riboswitches in vivo versus the in vitro
situation.
Undoubtedly, the finding of new riboswitches, the struc-
tural study of how they recognize their ligands, the mech-
anistic analysis of how they are synthezised and fold
in vivo, and how the binding of the ligands lead to confor-
mational changes that affect gene expression will give
more insight into how these regulatory RNA elements
function in living cells.
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